Almaatouq M A, Al-Arouj M, Amod A, Assaad-Khalil S H, Assaad S N, Azar S T, Esmat K, Hassoun A A K, Jarrah N, Zatari S
King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
Int J Clin Pract. 2014 Apr;68(4):503-11. doi: 10.1111/ijcp.12342. Epub 2014 Jan 29.
The prevalence of type 2 diabetes is increasing worldwide, but developing nations will bear a disproportionate share of this burden. Countries in the Middle East and Africa are in a state of transition, where marked disparities of income and access to education and healthcare exist, and where the relatively young populations are being exposed increasingly to processes of urbanisation and adverse changes in diet that are fuelling the diabetes epidemic. Optimising diabetes care in these nations is crucial, to minimise the future burden of complications of diabetes.
We have reviewed the barriers to effective diabetes care with special relevance to countries in this region.
The effects of antidiabetic treatments themselves are unlikely to differ importantly in the region compared with elsewhere, but economic inequalities within countries restrict access to newer treatments, in particular. Values relating to family life and religion are important modifiers of the physician-patient interaction. Also, a lack of understanding of diabetes and its treatments by both physicians and patients requires more and better diabetes education, delivered by suitably qualified health educators. Finally, sub-optimal processes for delivery of care have contributed to a lack of proper provision of testing and follow-up of patients in many countries.
Important barriers to the delivery of optimal diabetes care exist in the Middle East and Africa.
2型糖尿病在全球的患病率正在上升，但发展中国家将承担与此不成比例的负担。中东和非洲国家正处于转型期，存在明显的收入差距以及获得教育和医疗保健的机会不平等，而且相对年轻的人口越来越多地受到城市化进程和饮食不良变化的影响，这些因素正在助长糖尿病的流行。在这些国家优化糖尿病护理至关重要，以尽量减少糖尿病并发症的未来负担。
我们回顾了有效糖尿病护理的障碍，特别关注该地区的国家。
与其他地方相比，该地区抗糖尿病治疗本身的效果不太可能有重要差异，但各国国内的经济不平等尤其限制了获得更新治疗方法的机会。与家庭生活和宗教相关的价值观是医患互动的重要调节因素。此外，医生和患者对糖尿病及其治疗方法缺乏了解，这需要由合格的健康教育工作者提供更多更好的糖尿病教育。最后，次优的护理提供流程导致许多国家对患者的检测和随访不足。
中东和非洲在提供最佳糖尿病护理方面存在重要障碍。
